Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: a phase Ib/randomized phase II trial - Concepedia

Concepedia

Publication | Open Access

Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: a phase Ib/randomized phase II trial

DOI Full Paper Access

161

Citations

9

References

2019

Year

Tibor Csőszi, Marina Maglakelidze, Robert J. Hoyer, J.T. Beck, M. Dómine Gómez, Raid Aljumaily, Caio M. Rocha Lima, Ralph V. Boccia, Wahid T. Hanna, Petros Nikolinakos,

Annals of Oncology

References

	Year	Citations

Page 1